256 related articles for article (PubMed ID: 18991586)
1. Permeability for intestinal absorption: Caco-2 assay and related issues.
Press B; Di Grandi D
Curr Drug Metab; 2008 Nov; 9(9):893-900. PubMed ID: 18991586
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux.
Press B
Methods Mol Biol; 2011; 763():139-54. PubMed ID: 21874449
[TBL] [Abstract][Full Text] [Related]
3. Applications of a 7-day Caco-2 cell model in drug discovery and development.
Peng Y; Yadava P; Heikkinen AT; Parrott N; Railkar A
Eur J Pharm Sci; 2014 Jun; 56():120-30. PubMed ID: 24576578
[TBL] [Abstract][Full Text] [Related]
4. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
5. Strategies for absorption screening in drug discovery and development.
Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
[TBL] [Abstract][Full Text] [Related]
6. Caco-2 cells as a model for intestinal absorption.
Angelis ID; Turco L
Curr Protoc Toxicol; 2011 Feb; Chapter 20():Unit20.6. PubMed ID: 21400683
[TBL] [Abstract][Full Text] [Related]
7. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Lin X; Skolnik S; Chen X; Wang J
Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
[TBL] [Abstract][Full Text] [Related]
9. Advances in cell-based permeability assays to screen drugs for intestinal absorption.
Volpe DA
Expert Opin Drug Discov; 2020 May; 15(5):539-549. PubMed ID: 32154737
[No Abstract] [Full Text] [Related]
10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
11. Prediction of oral drug absorption in humans--from cultured cell lines and experimental animals.
Cheng KC; Li C; Uss AS
Expert Opin Drug Metab Toxicol; 2008 May; 4(5):581-90. PubMed ID: 18484916
[TBL] [Abstract][Full Text] [Related]
12. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2015 Jan; 67():126-135. PubMed ID: 25433246
[TBL] [Abstract][Full Text] [Related]
14. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.
Skolnik S; Lin X; Wang J; Chen XH; He T; Zhang B
J Pharm Sci; 2010 Jul; 99(7):3246-65. PubMed ID: 20166204
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis.
Markowska M; Oberle R; Juzwin S; Hsu CP; Gryszkiewicz M; Streeter AJ
J Pharmacol Toxicol Methods; 2001; 46(1):51-5. PubMed ID: 12164260
[TBL] [Abstract][Full Text] [Related]
16. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
17. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
18. Caco-2 cell permeability assays to measure drug absorption.
van Breemen RB; Li Y
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):175-85. PubMed ID: 16922635
[TBL] [Abstract][Full Text] [Related]
19. Three-Compartment Model Analysis with Minimal Sampling Points in the Caco-2 Permeability Assay.
Nagayasu M; Ozeki K; Onoue S
Biol Pharm Bull; 2019; 42(9):1600-1604. PubMed ID: 31474721
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development.
Fredlund L; Winiwarter S; Hilgendorf C
Mol Pharm; 2017 May; 14(5):1601-1609. PubMed ID: 28329446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
